Biology, asked by Assassinator7170, 1 year ago

Biocon: launching a new cancer drug in india case analysis

Answers

Answered by arianagrande4
0

Audiobooks Magazines News Documents Sheet Music More info Toggle Fullscreen Download  1 You are on page 1of 5 Search document Search document     Marketing Management Case Analysis:   Biocon: Launching a new cancer drug in India   Indian Institute of ManagementKozhikodeSubmitted By:PGP/14/258 Alok Kumar PGP/14/279 Lokesh SinghPGP/14/280 Mahtaab Kajla PGP/14/283 Naveen VyasPGP/14/303 Shruti Kabdal PGP/14/304 Sneha Ramteke Submitted to: Prof. Rahul Kumar Sett      1 Situation Analysis    Biocon was the first Indian company to manufacture and export enzymes to US and Europe in the year 1979.    It was primarily into enzyme manufacturing from 1978 to 1997.    Eventually, in 2001, it started manufacturing insulin.    Formed a Joint Venture with CIMAB to develop and market BIOMAb in India

Similar questions